237 related articles for article (PubMed ID: 12234170)
1. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
Lee Sk; Cook EF; Soiffer R; Antin JH
Biol Blood Marrow Transplant; 2002; 8(8):444-52. PubMed ID: 12234170
[TBL] [Abstract][Full Text] [Related]
2. Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.
Vasconcellos de Souza C; Vigorito AC; Miranda ECM; Garcia C; Rensi Colturato VA; Mauad MA; Rodrigues Moreira MC; da Silva Bouzas LF; Lermontov S; Hamerschlak N; Rodrigues M; Carlos de Almeida Barros J; Chiattone R; Lee SJ; Flowers MED
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1313-1318. PubMed ID: 27058616
[TBL] [Abstract][Full Text] [Related]
3. Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
Merkel EC; Mitchell SA; Lee SJ
Biol Blood Marrow Transplant; 2016 Apr; 22(4):752-758. PubMed ID: 26751003
[TBL] [Abstract][Full Text] [Related]
4. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
[TBL] [Abstract][Full Text] [Related]
5. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.
Herzberg PY; Lee SJ; Heussner P; Mumm FH; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix HT; Freund M; Holler E; Wolff D
Bone Marrow Transplant; 2013 Jan; 48(1):129-34. PubMed ID: 22609882
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes and health status associated with chronic graft-
Lee SJ; Onstad L; Chow EJ; Shaw BE; Jim HSL; Syrjala KL; Baker KS; Buckley S; Flowers ME
Haematologica; 2018 Sep; 103(9):1535-1541. PubMed ID: 29858386
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.
Pidala J; Kurland BF; Chai X; Vogelsang G; Weisdorf DJ; Pavletic S; Cutler C; Majhail N; Lee SJ
Haematologica; 2011 Oct; 96(10):1528-35. PubMed ID: 21685473
[TBL] [Abstract][Full Text] [Related]
8. Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
Perić Z; Desnica L; Duraković N; Ostojić A; Pulanić D; Serventi-Seiwerth R; Prenc E; Basak G; Vrhovac R; Pavletic SZ; Nemet D
Croat Med J; 2016 Feb; 57(1):6-15. PubMed ID: 26935610
[TBL] [Abstract][Full Text] [Related]
9. Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.
Lutz M; Kapp M; Einsele H; Grigoleit GU; Mielke S
Clin Transplant; 2014 Dec; 28(12):1410-5. PubMed ID: 25287756
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
[TBL] [Abstract][Full Text] [Related]
11. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
[TBL] [Abstract][Full Text] [Related]
12. Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.
DePalo J; Chai X; Lee SJ; Cutler CS; Treister N
Oral Oncol; 2015 Oct; 51(10):944-9. PubMed ID: 26277616
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
[TBL] [Abstract][Full Text] [Related]
14. A survey of diagnosis, management, and grading of chronic GVHD.
Lee SJ; Vogelsang G; Gilman A; Weisdorf DJ; Pavletic S; Antin JH; Horowitz MM; Akpek G; Flowers ME; Couriel D; Martin PJ
Biol Blood Marrow Transplant; 2002; 8(1):32-9. PubMed ID: 11846354
[TBL] [Abstract][Full Text] [Related]
15. Symptoms, Cytokines, and Quality of Life in Patients Diagnosed with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
Lynch Kelly D; Lyon DE; Ameringer SA; Elswick RK
Oncol Nurs Forum; 2015 May; 42(3):265-75. PubMed ID: 25901378
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
17. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
[TBL] [Abstract][Full Text] [Related]
18. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
19. Reliability and Validity of the Modified 7-Day Lee Chronic Graft-versus-Host Disease Symptom Scale.
Teh C; Onstad L; Lee SJ
Biol Blood Marrow Transplant; 2020 Mar; 26(3):562-567. PubMed ID: 31759158
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
